Home Numinus

Numinus

acquired
IPO
Psychedelic Drug Developer
Basic
Enterprise Profile

Basic Information

Numinus exists to heal the world, first by harnessing the power and promise of psychedelics to address the global mental health crisis. Through our integrated model, we actively contribute to foundational and clinical psychedelic research while delivering first-class treatment options in our clinics.
Numinus Wellness Inc.
Vancouver,BritishColumbia,Canada
101~500 people
January 01, 2019
--

Enterprise Profile

Industrial Sector
New Drug Development
Concept
Department of Psychiatry Therapeutic Products
Application Scenarios
Innovative Drugs